Mark Ragosa

Chief Financial Officer at Kiniksa Pharmaceuticals

Mark is the VP Interim Chief Financial Officer. He joined Kiniksa prior to the company’s initial public offering in 2018. Mark is responsible for establishing and expanding Kiniksa’s relationships with its global investor base and industry analysts through communicating the company’s business principles, corporate strategy and financial performance. He also provides input on corporate communications, financial operations and other shareholder-related activities. Mark joined Kiniksa from Ironwood Pharmaceuticals, where he was a member of the investor relations team. Prior to Ironwood, Mark was a Vice President in the equities division at Goldman Sachs where he built strategic relationships with key hedge fund and mutual fund companies and helped raise capital for private and public companies. Mark also held roles of increasing responsibility within the equities divisions of Morgan Stanley and Bank of America Securities. Mark has over 20 years of experience in the financial services and life sciences industries. He has a strong understanding of institutional investor needs as well as an extensive knowledge of finance and equity markets.

Mark holds a BA in Government and History from Bowdoin College and is a Chartered Financial Analyst.

Links

Timeline

  • Chief Financial Officer

    Current role

  • VP Interim Chief Financial Officer